July 25, 2007
Caris Diagnostics Announces Expansion in Dermatopathology
Caris Diagnostics, the leading provider of subspecialty focused pathology services to outpatient physicians, today announced the expansion of its dermatopathology team through the addition of three highly-respected and accomplished physicians. Mary Landau-Levine, M.D. has joined Caris Diagnostics in Phoenix to lead the Arizona-based dermatopathology practice for the company. She will be joined by David Glembocki, M.D. in August. In addition, Tom Horn, M.D. joined the Caris Cohen Dx team in Newton, MA last month. With these additions, Caris Diagnostics will have seven dermatopathologists providing professional consultations for its clinicians and their patients.
"While we remain highly dedicated to the GI market, we continue to deepen our commitment to dermatopathology that we initiated last month through our combination with Cohen Dermatopathology," commented Gail Marcus, President and Chief Executive Officer of Caris Diagnostics. "Our Phoenix facility is ready to support this expansion into our new subspecialty. Given our intense focus on quality as the key priority in our operations, we continue to have success attracting the highest caliber pathologists in the country. We welcome Drs. Landau-Levine, Glembocki and Horn into our company, and we are pleased to have such a strong foundation from which to expand our dermatopathology subspecialty."Dr. Landau-Levine joins Caris Diagnostics from Scottsdale Pathology Consultants, where she practiced for eight years and was President of the organization. In her practice, Dr. Landau-Levine specializes in the diagnosis of recalcitrant skin conditions, skin manifestations related to aging and photodamage, as well as the evaluation of skin lesions for carcinoma and difficult melanocytic lesions. She received The American Federation of Clinical Research Award and The American Medical Women's Award and has served as Chairman of Pathology for Scottsdale Healthcare, Shea Campus. Dr. Landau-Levine is board-certified in dermatopathology and anatomic and clinical pathology.
Dr. Glembocki is also joining Caris Diagnostics from Scottsdale Pathology Consultants, where he practiced for four years. He is board-certified in dermatopathology and anatomic and clinical pathology. Dr. Glembocki completed his fellowship training in dermatopathology and surgical pathology at the University of Virginia and was Chief Resident in the Department of Pathology during that time.
Dr. Horn is board-certified in both dermatology and dermatopathology. Most recently, he was the Chairman of the Department of Dermatology at the University of Arkansas for Medical Sciences, as well as a professor of Dermatology and Pathology. Dr. Horn also served as the Chief of Dermatology for the Central Arkansas Veterans Healthcare Systems. In addition to these academic and institutional appointments, Dr. Horn is a director and President-elect of the American Board of Dermatology, chairman and member of the Residency Review Committee for Dermatopathology and past President of the American Society of Dermatopathology. His special clinical interests include melanomas, pigmented lesions and HIV-related skin diseases.
"We are thrilled to continue to have such well-renowned academic leaders as Dr. Horn choose to join our team," concluded Richard H. Lash, M.D., Chief Medical Officer of Caris Diagnostics. "These talented pathologists reinforce our commitment to providing academic-caliber medicine in a commercial setting and help attract additional highly qualified physicians to our company."
About Caris Diagnostics
Caris Diagnostics provides world-class surgical pathology services to physicians who treat patients in an ambulatory setting. The company provides its academic-caliber medical consults through its industry-leading team of subspecialty fellowship and expert trained pathologists in gastrointestinal and liver pathology and dermatopathology. The company provides the highest levels of service to its clinician customers and their patients through its state-of-the-art laboratories, proprietary, advanced clinical practice solutions, and rigorous quality assurance programs. More than 1,500 physicians nationally use Caris Diagnostics. Formed in 1996, the company is headquartered in Irving, Texas and operates three laboratories in Irving, Texas; Phoenix, Arizona; and Newton, Massachusetts. Additional information is available at www.carisdx.com or by calling 214-277-8700.